Invesco
VASC

Invesco’s Vascular Solutions Inc VASC Stock Holding History

Invesco’s Portfolio VASC Stock Details VASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-80,827
Closed -$4.53M – 3826
2016
Q4 		$4.53M Sell
80,827
-25,801
-24% -$1.31M ﹤0.01% 2039
2016
Q3 		$5.14M Buy
106,628
+52,866
+98% +$2.46M ﹤0.01% 1957
2016
Q2 		$2.24M Sell
53,762
-23,564
-30% -$877K ﹤0.01% 2415
2016
Q1 		$2.52M Sell
77,326
-36,919
-32% -$1.06M ﹤0.01% 2325
2015
Q4 		$3.93M Buy
114,245
+3,609
+3% +$122K ﹤0.01% 2073
2015
Q3 		$3.59M Buy
110,636
+11,302
+11% +$405K ﹤0.01% 2098
2015
Q2 		$3.45M Buy
99,334
+58,487
+143% +$1.91M ﹤0.01% 2264
2015
Q1 		$1.24M Buy
40,847
+40,383
+8,703% +$1.16M ﹤0.01% 2914
2014
Q4 		$13K Buy
464
+13
+3% +$353 ﹤0.01% 3987
2014
Q3 		$11K Buy
451
+1
+0.2% +$24 ﹤0.01% 4028
2014
Q2 		$10K Hold
450
– – ﹤0.01% 4018
2014
Q1 		$12K Sell
450
-101
-18% -$2.51K ﹤0.01% 4017
2013
Q4 		$13K Buy
551
+10
+2% +$196 ﹤0.01% 4194
2013
Q3 		$9K Hold
541
– – ﹤0.01% 4228
2013
Q2 		$8K Buy
+541
New +$8.51K ﹤0.01% 4207

Other funds holding VASC

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Invesco's VASC Position: Q1 2017 in Review

Invesco sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 80,827 shares — an estimated $4.53M sold.

Invesco first reported a position in VASC in Q2 2013 and held it in 15 quarters. The position peaked at $5.14M in Q3 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • Invesco reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • Invesco sold 80,827 Vascular Solutions Inc shares in Q1 2017, an estimated $4.53M.
  • Invesco first reported a position in Vascular Solutions Inc in Q2 2013 and held it in 15 quarters.
  • Invesco's Vascular Solutions Inc position peaked at $5.14M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on Invesco's 13F filing for Q1 2017, filed 15 May 2017.